Altogether, these data suggest that dysregulated AQP7 expression is linked to dysregulated insulin secretion, thereof suggesting AQP7 as a potential therapeutic target for human obesity-associated type 2 diabetes. The gene discussed is AQP7; the disease is type 2 diabetes mellitus.